Vidhya Murthy Profile
Vidhya Murthy

@VidhyaMurthy1

Followers
294
Following
2K
Statuses
465

Consultant Haematologist with an interest in myeloid malignancies.

Birmingham, England
Joined March 2020
Don't wanna be here? Send us removal request.
@VidhyaMurthy1
Vidhya Murthy
3 days
RT @BloodJournal: Menin inhibitors in the treatment of acute myeloid leukemia #bloodspotlight #myeloidneoplasia htt…
0
29
0
@VidhyaMurthy1
Vidhya Murthy
5 days
RT @jayastuMD: 🙏🙂 Very happy to share our manuscript on a granular analysis of a large cohort of Secondary Type AML with respect to contemp…
0
27
0
@VidhyaMurthy1
Vidhya Murthy
5 days
RT @smbenlazar: How I treat refractory and relapsed acute myeloid leukemia #AML #leusm
Tweet media one
0
39
0
@VidhyaMurthy1
Vidhya Murthy
9 days
RT @TalhaBadarMD: Finally published online: T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute m…
0
4
0
@VidhyaMurthy1
Vidhya Murthy
9 days
RT @diegoah66: Treatment of lower-risk myelodysplastic syndromes | Haematologica
0
3
0
@VidhyaMurthy1
Vidhya Murthy
16 days
RT @smbenlazar: Venetoclax 50 mg in combination with posaconazole resulted in PK parameters most similar to that observed with VEN without…
0
29
0
@VidhyaMurthy1
Vidhya Murthy
17 days
RT @BrJHaem: Origins of T-cell-mediated autoimmunity in acquired aplastic anaemia
Tweet media one
0
17
0
@VidhyaMurthy1
Vidhya Murthy
25 days
RT @MostafaFaisal14: Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children @BrJHaem htt…
0
6
0
@VidhyaMurthy1
Vidhya Murthy
27 days
RT @isro: SpaDeX Docking Update: 🌟Docking Success Spacecraft docking successfully completed! A historic moment. Let’s walk through the S…
0
10K
0
@VidhyaMurthy1
Vidhya Murthy
1 month
RT @TalhaBadarMD: #Weekend_review Will discuss #DDX41mt most unique and most prevalent germline predisposition syndrome in myeloid neopl…
0
14
0
@VidhyaMurthy1
Vidhya Murthy
2 months
RT @jayastuMD: ➡️ Check out our manuscript just published in @AjHematology on Treated Secondary-AML: 673 patients, largest reported cohort…
0
41
0
@VidhyaMurthy1
Vidhya Murthy
2 months
Tweet media one
0
3
0
@VidhyaMurthy1
Vidhya Murthy
2 months
RT @goldstone_tony: If you missed the live launch catch up below 👇 Launch video catchup: Download the excel Free…
0
4
0
@VidhyaMurthy1
Vidhya Murthy
2 months
RT @TalhaBadarMD: #Weekend_review #ASH24 Selected abstract in acute leukemia and MDS Important insights! 🧵 #leusm #mdssm #AML #ALL
0
9
0
@VidhyaMurthy1
Vidhya Murthy
2 months
RT @smbenlazar: Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy htt…
0
5
0
@VidhyaMurthy1
Vidhya Murthy
2 months
RT @Kasparov63: Gukesh was well-prepared and the player who played the best won the match. His victory caps a phenomenal year for India. Co…
0
1K
0
@VidhyaMurthy1
Vidhya Murthy
2 months
RT @AML_Hub: CONGRESS | #ASH24 | POSTER @drpramilak, @KingsCollegeNHS, presents a retrospective observational study on treatment patterns a…
0
6
0
@VidhyaMurthy1
Vidhya Murthy
2 months
RT @smbenlazar: TP53 mutants and Len therapy/maintenance #mmsm #ASH24
Tweet media one
0
7
0
@VidhyaMurthy1
Vidhya Murthy
3 months
RT @MostafaFaisal14: Acute Leukemias of Ambiguous Lineage With MDS-Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Le…
0
11
0
@VidhyaMurthy1
Vidhya Murthy
3 months
RT @MostafaFaisal14: Basophilia Predicts Poorer Outcomes in Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis, and Myelop…
0
14
0